Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07403552
PHASE1

Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants

Sponsor: Ensho Therapeutics, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the pharmacokinetics, safety, and tolerability of NSHO-101 in Healthy Participants.

Official title: A Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-01-31

Completion Date

2026-06

Last Updated

2026-02-11

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

NSHO-101

Dose form - tablet Route of administration - oral Regimen / Treatment period - QD for 14 days

Locations (1)

Cenexel Anaheim CA

Anaheim, California, United States